SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eikon Therapeutics Presents New EIK1001 Data in Advanced Lung Cancer

Eikon Therapeutics presented new study data for EIK1001 in advanced lung cancer.

EIKN

Related stories